Loading provider…
Loading provider…
Nephrology Physician in Syracuse, NY
NPI: 1073729463Primary Practice Location
UNIVERSITY HOSPITAL S U N Y HEALTH SCIENCE CENTER
4900 Broad Rd, Syracuse, NY
Primary Employer
Department of Medicine Medical Serv Grp at SUNY Hlth Sci Ctr Syr In
upstatemedicine.com
HQ Phone
Get M.D. Michael's Phone Numberphone_androidMobile
Get M.D. Michael's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardPA State Medical License
NY State Medical License

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Nephrology
University at Buffalo School of Medicine
Medical School
Until 1999
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 90935Hemodialysis procedure with one physician evaluation | 74 | 198 |
| 2 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 59 | 109 |
| 3 | 99223Initial hospital inpatient care, typically 70 minutes per day | 57 | 59 |
| 4 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 48 | 84 |
| 5 | 90960Dialysis services (4 or more physician visits per month), patient 20 years of age and older | 39 | 39 |
Authors: Garisto, Juan, Bertolo, Riccardo, Agudelo, Jose, Armanyous, Sherif, Gao, Tianming, Lioudis, Michael, Kaouk, Jihad H
Journal: Minerva Urol Nefrol
Publication Date: 2018-11-07
Authors: Bertolo, Riccardo, Garisto, Juan, Dagenais, Julien, Agudelo, Jose, Armanyous, Sherif, Lioudis, Michael, Kaouk, Jihad
Journal: J Endourol
Authors: Lioudis, Michael, Zhou, Xiaolei, Davenport, Eric, Nunna, Sasikiran, Krasa, Holly B, Oberdhan, Dorothee, Fernandes, Ancilla W
Journal: BMC Nephrol
Publication Date: 2023-06-22
Lead Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: Tolvaptan (OPC-41061)